Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

NCT: NCT04354077 · RECRUITING

NCT IDNCT04354077
StatusRECRUITING
Start Date2022-02-07
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (OTHER)
First posted
Last updated

Brief Summary

This is a pilot study to evaluate the safety and efficacy of deep brain stimulation (DBS) of the nucleus accumbens (NAc) as adjunctive treatment for treatment-refractory opioid use disorder. This study will include 3 individuals with opioid use disorder and relapsing opioid use despite active participation in a drug addiction treatment program.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑